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In this issue of Chemistry & Biology, Gross et al. [1] report development of a novel genome mining
method for isolating products of orphan biosynthetic gene clusters, and the application of this
method to the isolation of orfamide A, a novel cyclic lipopeptide.Before the genomics revolution, the
isolation of new natural products relied
exclusively on the detection of bio-
activity in extracts fromnatural sources
oronphysico-chemicalproperties, e.g.,
the presence of a chromophore. Purifi-
cation of compounds identified in
these ways was achieved by assay-
guided fractionation. The most ex-
plored bioactivity assay targeted anti-
biotic activity. Using this approach,
penicillin was isolated from Penicillium
notatum, sparking the ‘‘Golden Age
of Antibiotics,’’ which spanned the
1940s to the 1970s. During this pe-
riod, the pharmaceutical industry was
deeply engaged in the search for new
natural products. At the end of the
20th century, the supply of new natural
products from this assay-guided ap-
proach appeared to be almost ex-
hausted,mainlybecauseknownnatural
products were rediscovered with high
frequency [2].
With the new century, the power of
genomics generated new methodo-
logies for isolating novel natural prod-
ucts. Indeed, the large quantity of
publicly accessible DNA sequence
data opened the way for exploitation
of bioinformatics tools for new natural
product discovery. Using these tools,
several microbial genomes have been
found to contain so-called ‘‘cryptic’’
or ‘‘orphan’’ gene clusters encoding
putative biosynthetic enzymes likely
to be involved in the production of un-knownandpotentially novel secondary
metabolites [3–7]. The putative func-
tion and substrate specificity of some
of these proteins, e.g., modular nonri-
bosomal peptide synthetase (NRPS)
and polyketide synthase (PKS) multi-
enzymes could also be predicted. Ge-
nome mining for novel nonribosomal
peptide natural products began in
2000, when a cryptic NRPS encoded
within the Streptomyces coelicolor A3(2)
genome sequence was discovered
and the substrate specificity of this
system was predicted [9], allowing
physicochemical properties of the me-
tabolite to be proposed. Using a gene
knockout/comparative metabolic pro-
filing strategy (Figure 1), the product
of this NRPS—coelichelin—was dis-
covered [8]. In the last three years, the
discovery of several novel polyketides
and terpenoids by genomemining em-
ploying a variety of approaches (Fig-
ure 1) has been reported [7, 10–16, 19].
In this issue of Chemistry & Biology,
Gross et al. report the development of
a new tool for genome mining that
promises to significantly expand the
current armamentarium (Figure 1, red
box), and its application to the isolation
of a novel bioactive nonribosomal
peptide product of an orphan gene
cluster identified in the Pseudomonas
fluorescens Pf-5 genome sequence
[1]. Bioinformatics tools predicted the
substrate specificity of the NRPS en-
coded within the gene cluster, leadingChemistry & Biology 14, January 2007to thehypothesis that it directs produc-
tion of a novel lipopeptide containing
four leucine residues. This hypothesis
led to the idea of using 1H-15N HMBC
NMR spectroscopy to guide its purifi-
cation from cultures of P. fluorescens
fed with 15N-labeled leucine, dubbed
‘‘the genomisotopic approach’’ by the
authors. A traditional bioassay-guided
purification was also set up in parallel.
Both approaches resulted in the iso-
lation of orfamide A, along with minor
amounts of two analogs.
The novelty of the genomisotopic
approach resides in the combination
of predictions from genomics with the
exploitation of stable-isotope-labeled
precursor incorporation. Since the
advent of routine multinuclear NMR
spectroscopy in 1970s, stable-isotope
labeled precursors have beenpowerful
tools for investigating the biosynthetic
origins of natural products. However
developments in our understanding of
the genetics andenzymologyof natural
product biosynthesis in recent years
have been accompanied by a decline
in the use of stable isotopes to investi-
gate biosynthetic pathways.
The genomisotopic approach is a
potentially quite general genome min-
ing tool for the isolation of new non-
ribosomal peptide natural products,
because at least some of the sub-
strates of NRPSs with known se-
quence, but unknown function, can
be predicted with a reasonable degreeª2007 Elsevier Ltd All rights reserved 7
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PreviewsFigure 1. Schematic Representations of Different Strategies for the Isolation of New Natural Products by Genome Miningof confidence. In these cases, it should
be possible to identify appropriate 15N-
labeled amino acids to feed for HMBC-
guided fractionation. For other modu-
lar biosynthetic systems such as
modular PKSs, substrate specificity is
less easy to predict, although ad-
vances continue to be made in this
area [12]. Thus, the genomisotopic
approach may be more limited for the
isolation of new polyketide natural
products by genome mining. With the
continuing development of bioinfor-
matics tools and the expansion in
knowledge of diverse natural product
biosynthetic systems [17], labeled pre-
cursors could be used in conjunction
with 2-D NMR analyses to guide the
isolation of novel natural products be-
longing to other classes besides non-
ribosomal peptides and polyketides.
The approach could also be utilized
to target tailoring steps that add ‘‘fin-
ishing touches’’ to structures after
assembly of the natural product back-
bone is complete. For example identifi-
cation of a gene encoding an O- or
N-methyltransferase in an orphan
gene cluster might suggest feeding of
[13C-methyl]methionine in conjunction
with 1H-13C HMBC NMR analyses8 Chemistry & Biology 14, January 2007 ªas a strategy for identification of the
product of the orphan cluster.
The major limiting factors for the ge-
nomisotopic approach are the accu-
racy with which substrate predictions
from sequence data can be made,
and the availability of appropriate la-
beled precursors. Choosing the opti-
mal labeling pattern for the most
appropriate predicted precursor is cru-
cial. Ideally, the incorporation of the
label into the cryptic natural product
should be direct, specific, and high
yielding. Incorporation of the labeled
precursor into other metabolites could
result in the isolation of natural prod-
ucts unlinked to the targeted orphan
gene cluster. Other parameters such
as timing of feeding and concentration
of precursors fed are also critical to
get good levels of specific incorpora-
tion. In the case of orfamide A, four
leucine residues were predicted to be
incorporated. This multiplicity of leu-
cine residues afforded a higher level
of isotope incorporation and lowered
thechancesof no incorporation of label
resulting from NRPS module skipping
[8,18] or inaccurate prediction of NRPS
substrate specificity. For biosynthetic
gene clusters where few or no predic-2007 Elsevier Ltd All rights reservedtions about the substrate specificity of
the encoded enzymes can be made,
other approaches such as gene knock-
out/comparativemetabolicprofiling (Fig-
ure 1) are superior to the genomisotopic
approach, because they do not rely on
such predictions [19].
A significant obstacle to discovery
ofnewnaturalproductsbygenomemin-
ing is lowor no expression of the cryptic
(orphan) gene cluster under investiga-
tion. Expression of the genes in a cluster
can be readily examined by RT-PCR,
as demonstrated by Gross et al. in the
orfamide study [1]. If the gene cluster is
silent, different growth conditions can
be examined for activation of gene
expression. Manipulation of pleiotropic
regulators of secondary metabolism
shows potential as amethod to activate
expression of silent gene clusters in
filamentous fungi [6], but general meth-
ods for achieving this in diverse organ-
isms are still lacking. One approach
might be to overexpress pathway-
specific activators, e.g., SARPs, which
specifically activate the expression of
many secondary metabolic gene clus-
ters in Streptomyces spp. [20].
While the genomisotopic approach
offers potential for rapid isolation of
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ingwithout requiring geneticmanipula-
tion of the producing organism, linkage
between the metabolite isolated and
the orphan gene cluster hypothesized
to direct its production still needs
to be established. This is usually
achieved by demonstrating that in-
activation of a biosynthetic gene abro-
gates production of the metabolite or
that transfer of the gene cluster to
a heterologous host results in metabo-
lite production (Figure 1). Thus, genetic
manipulations are ultimately still
required.
It will be interesting to see whether
the genomisotopic approach can be
applied to the identification of other
novel compounds whose existence is
implicated by analysis of genome se-
quence data. Continued development
of predictive bioinformatics tools for
natural product biosyntheticmachinery
is essential to ensure broad applicabil-
ity of the genomisotopic approach.
Nevertheless, the recent emergence
of diversemethodologies for newnatu-
ral product discovery by genome min-
ing may provide the impetus needed
to nudge pharmaceutical companies
back into large-scale natural product
drug discovery programs.A Designed RNA
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Using an in vivo selection strategy
gene transcription in yeast [1]. In
long-believed ‘‘protein-only’’ cell
The discovery of catalytic RNA more
than 20 years ago initiated a new era
of RNA research [2, 3]. This first dis-
covery that RNA can be both an infor-
mational molecule and a catalyst
caused a shift in thinking about RNA
in general. In a virtually continual ex-
pansion, a plethora of RNA molecules
with diverse catalytic and regulatory
functions have emerged, indicatingREFERENCES
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Amolecule capable of silencing
e of RNA molecules performing
three-dimensional structures for the
precise presentation of chemicalmoie-
ties that are essential for its function
as a biological catalyst, structural scaf-
fold, or regulator of gene expression.
Molecular engineers began to har-
ness Darwinian evolution in combina-
tion with rational design to optimize
the known functions of RNA, but also
to create ‘‘new’’ ones. For example,
ª2007 Elsevier Ltd All rights reserved 9
